Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001002014-15-000219
Filing Date
2015-05-15
Accepted
2015-05-15 15:03:01
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 THC FARMACEUTICALS, INC. FORM 10-Q (3/31/2015) cbdg10q-3312015.htm 10-Q 241002
2 SARBANES-OXLEY 302 CERTIFICATION - PRINCIPAL EXECUTIVE OFFICER exh31-1.htm EX-31.1 11059
3 SARBANES-OXLEY 302 CERTIFICATION - PRINCIPAL FINANCIAL OFFICER exh31-2.htm EX-31.2 11053
4 SARBANES-OXLEY 906 CERTIFICATION - CHIEF EXECUTIVE OFFICER exh32-1.htm EX-32.1 4548
5 SARBANES-OXLEY 906 CERTIFICATION - CHIEF FINANCIAL OFFICER exh32-2.htm EX-32.2 4543
  Complete submission text file 0001002014-15-000219.txt   956465

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbdg-20150331.xml EX-101.INS 32584
7 XBRL TAXONOMY EXTENSION - SCHEMA cbdg-20150331.xsd EX-101.SCH 10628
8 XBRL TAXONOMY EXTENSION - CALCULATIONS cbdg-20150331_cal.xml EX-101.CAL 17815
9 XBRL TAXONOMY EXTENSION - DEFINITIONS cbdg-20150331_def.xml EX-101.DEF 51967
10 XBRL TAXONOMY EXTENSION - LABELS cbdg-20150331_lab.xml EX-101.LAB 70606
11 XBRL TAXONOMY EXTENSION - PRESENTATION cbdg-20150331_pre.xml EX-101.PRE 53723
Mailing Address 7170 E. MCDONALD DRIVE SUITE 3 SCOTTSDALE AZ 85253
Business Address 7170 E. MCDONALD DRIVE SUITE 3 SCOTTSDALE AZ 85253 480-725-9060
THC Farmaceuticals, Inc. (Filer) CIK: 0001508594 (see all company filings)

EIN.: 261805170 | State of Incorp.: UT | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-54754 | Film No.: 15868325
SIC: 6199 Finance Services